drugset / Trial / NCT01240096

Mirtazapine Versus Placebo in Functional Dyspepsia

NCT01240096

Phase 4 Completed 35 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Double-blind randomized controlled trials of 8 weeks mirtazapine 15 mg daily or placebo, followed by 8 weeks of open-label mirtazapine 15 mg daily

Timeline

Start
2006-09-01
Primary completion
2011-08-01
Completion
2012-09-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mirtazapine Other / unclassified 15 mg

Indications